ME02294B - Phosphoramidates de nucléosides - Google Patents

Phosphoramidates de nucléosides

Info

Publication number
ME02294B
ME02294B MEP-2015-199A MEP19915A ME02294B ME 02294 B ME02294 B ME 02294B ME P19915 A MEP19915 A ME P19915A ME 02294 B ME02294 B ME 02294B
Authority
ME
Montenegro
Prior art keywords
methyltetrahydrofuran
phosphoryl
dioxo
phenoxy
fluoro
Prior art date
Application number
MEP-2015-199A
Other languages
English (en)
Unknown language (me)
Inventor
Bruce S Ross
Michael Joseph Sofia
Ganapati Reddy Pamulapati
Suguna Rachakonda
Hai-Ren Zhang
Byoung-Kwon Chun
Peiyuan Wang
Original Assignee
Gilead Pharmasset Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/783,680 external-priority patent/US8642756B2/en
Application filed by Gilead Pharmasset Llc filed Critical Gilead Pharmasset Llc
Priority claimed from EP11714465.9A external-priority patent/EP2552930B1/fr
Publication of ME02294B publication Critical patent/ME02294B/fr

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MEP-2015-199A 2010-03-31 2011-03-31 Phosphoramidates de nucléosides ME02294B (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US31951310P 2010-03-31 2010-03-31
US31954810P 2010-03-31 2010-03-31
US12/783,680 US8642756B2 (en) 2009-05-20 2010-05-20 Nucleoside phosphoramidates
EP11714465.9A EP2552930B1 (fr) 2010-03-31 2011-03-31 (s)-isopropyl 2-(((s)-(((2r,3r,4r,5r)-5-(2,4-dioxo-3,4-dihydropyrimidin-1-(2h)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino)propanoate cristallin
PCT/US2011/030725 WO2011123645A2 (fr) 2010-03-31 2011-03-31 Phosphoramidates de nucléosides

Publications (1)

Publication Number Publication Date
ME02294B true ME02294B (fr) 2016-02-20

Family

ID=55359000

Family Applications (2)

Application Number Title Priority Date Filing Date
MEP-2015-199A ME02294B (fr) 2010-03-31 2011-03-31 Phosphoramidates de nucléosides
MEP-2017-196A ME02846B (fr) 2010-03-31 2011-03-31 Phosphoramidates nucléosidiques

Family Applications After (1)

Application Number Title Priority Date Filing Date
MEP-2017-196A ME02846B (fr) 2010-03-31 2011-03-31 Phosphoramidates nucléosidiques

Country Status (4)

Country Link
BR (1) BR122013004621A2 (fr)
ME (2) ME02294B (fr)
RS (1) RS56229B1 (fr)
SI (1) SI2552930T1 (fr)

Also Published As

Publication number Publication date
SI2552930T1 (sl) 2016-02-29
ME02846B (fr) 2018-01-20
BR122013004621A2 (pt) 2016-11-22
RS56229B1 (sr) 2017-11-30

Similar Documents

Publication Publication Date Title
HRP20151075T1 (hr) Kristalni (s)-izopropil 2-(((s)-(((2r,3r,4r,5r)-5-(2,4-diokso-3,4-dihidropirimidin-1-(2h)-il)-4-fluoro-3-hidroksi-4-metiltetrahidrofuran-2-il)metoksi)(fenoksi)fosforil)amino) propanoat
HRP20211224T1 (hr) Derivati pirimidina za liječenje virusnih infekcija
IL207468A (en) HCV inhibitors and their use in the preparation of medicines for the treatment of HCV infections
HRP20151000T1 (hr) Antivirusni spojevi
ATE547103T1 (de) Hemmer des hepatitis-c-virus
EA022127B1 (ru) Ингибиторы вируса гепатита с
MX2010006210A (es) Inhibidores de serina proteasa de hcv de tripeptido fluorado.
JP2014504643A5 (fr)
JP2013521279A5 (fr)
WO2008002924A3 (fr) Inhibiteurs macrocycliques quinoxalinyliques des protéases à sérine du virus de l'hépatite c
JP2013514359A5 (fr)
JP2013532725A5 (fr)
MD20150036A2 (ro) Analogi de 2'-cloro nucleozide pentru tratarea hepatitei virale C
MX2010008699A (es) Derivados heterociclicos como inhibidores de virus de la hepatitis c.
JP2012504632A5 (fr)
MY169568A (en) Compounds and pharmaceutical compositions for the treatment of viral infections
CU23787B7 (es) Compuestos macrocíclicos como inhibidores de la replicación viral
WO2008021936A3 (fr) Inhibiteurs du virus de l'hépatite c
EA201491179A1 (ru) 2',4'-дифтор-2'-метил замещенные нуклеозидные производные в качестве ингибиторов репликации рнк вируса гепатита с
MX2010008109A (es) Tripéptidos difluorizados como inhibidores de proteasa de serina de virus de hepatitis c (hcv).
MX2010008108A (es) Inhibidores de proteasa de serina de tripéptido de virus de hepatitis c (hcv) que contienen heteroarilo.
ME02294B (fr) Phosphoramidates de nucléosides
MX2012002958A (es) Compuestos antivirales heterociclicos.
ATE491706T1 (de) Heterocyclische antivirale verbindungen
TH156755A (th) สารกลุ่มนิวคลีโอไซด์ฟอสฟอรามิเดต